HF Sinclair Corp (DINO) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value 0.11%; Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | 0.11% | Share-based compensation / revenue. Period ending 2026-06-30. $35.00M ÷ $31.23B × 100 ≈ 0.11% |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | |
| Revenue | 31.23B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | 35.00M USD | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 2.59B USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | Interest Expense · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $31.23B | $35.00M | $2.59B | (m) | (m) | 0.11% | (m) | (m) |
| 2026-03-31 | (m) | $27.62B | $35.00M | $1.69B | (m) | (m) | 0.13% | (m) | (m) |
| 2025-12-31 | (m) | $26.87B | $33.00M | $927.00M | (m) | (m) | 0.12% | (m) | (m) |
| 2025-09-30 | (m) | $26.91B | $28.00M | $694.00M | (m) | (m) | 0.10% | (m) | (m) |
| 2025-06-30 | (m) | $26.86B | $25.00M | $8.00M | (m) | (m) | 0.09% | (m) | (m) |
| 2025-03-31 | (m) | $27.92B | $23.00M | $-69.00M | (m) | (m) | 0.08% | (m) | (m) |
| 2024-12-31 | (m) | $28.58B | $23.00M | $261.00M | (m) | (m) | 0.08% | (m) | (m) |
| 2024-09-30 | (m) | $29.74B | $30.60M | $409.63M | (m) | (m) | 0.10% | (m) | (m) |
| 2024-06-30 | (m) | $31.44B | $37.33M | $1.60B | (m) | (m) | 0.12% | (m) | (m) |
| 2024-03-31 | (m) | $31.43B | $43.19M | $2.11B | $185.66M | (m) | 0.14% | 11.36× | Reported |
| 2023-12-31 | (m) | $31.96B | $41.13M | $2.20B | $190.80M | (m) | 0.13% | 11.54× | Reported |
| 2023-09-30 | (m) | $33.29B | $35.75M | $3.11B | $198.47M | (m) | 0.11% | 15.66× | Reported |
| 2023-06-30 | (m) | $34.98B | $30.33M | $3.36B | $194.61M | (m) | 0.09% | 17.28× | Reported |
| 2023-03-31 | (m) | $38.31B | $25.81M | $4.33B | $186.59M | (m) | 0.07% | 23.18× | Reported |
| 2022-12-31 | (m) | $38.20B | $30.32M | $4.05B | $175.63M | (m) | 0.08% | 23.08× | Reported |
| 2022-09-30 | (m) | $34.84B | $30.55M | $3.21B | $149.60M | (m) | 0.09% | 21.43× | Reported |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $18.39B | $39.27M | $749.19M | $125.17M | (m) | 0.21% | 5.99× | Reported |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $11.18B | $31.65M | $-733.74M | $126.53M | (m) | 0.28% | -5.80× | Reported |
| 2019-12-31 | (m) | $17.49B | $42.27M | $1.28B | $143.32M | (m) | 0.24% | 8.91× | Reported |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLAINS ALL AMERICAN PIPELINE LP (PAA) | United States | $17.385B | 5.05 |
| Delek Logistics Partners, LP (DKL) | United States | $2.896B | 17.80 |
| GENESIS ENERGY LP (GEL) | United States | $1.271B | 56.92 |
| MPLX LP (MPLX) | United States | $58.804B | 12.00 |